Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | KDM4E | B2RXH2 | 8/20 | 0.53 |
| ▸ | MEN1 | O00255 | 1/20 | 0.53 |
| ▸ | RECQL | P46063 | 1/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.53 |
| ▸ | L3MBTL1 | Q9Y468 | 4/20 | 0.47 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.47 |
| ▸ | LMNA | P02545 | 4/20 | 0.47 |
| ▸ | PKM | P14618 | 1/20 | 0.47 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.47 |
| ▸ | SMN1; SMN2 | Q16637 | 3/20 | 0.47 |
| ▸ | FABP3 | P05413 | 2/20 | 0.47 |
| ▸ | FABP7 | O15540 | 1/20 | 0.47 |
| ▸ | FABP5 | Q01469 | 1/20 | 0.47 |
| ▸ | MAPK1 | P28482 | 3/20 | 0.46 |
| ▸ | HTT | P42858 | 2/20 | 0.46 |
| ▸ | USP2 | O75604 | 1/20 | 0.46 |
| ▸ | MAPT | P10636 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.45 |
| ▸ | POLM | Q9NP87 | 1/20 | 0.45 |
| ▸ | POLK | Q9UBT6 | 1/20 | 0.45 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL34470443 | 1.00 | KDM4E (0.53) | KDM4EMEN1RECQLKMT2AL3MBTL1 | |
| SCHEMBL16236486 | 0.90 | KDM4E (0.66) | KDM4EMEN1RECQLKMT2AL3MBTL1 | |
| SCHEMBL27544260 | 0.89 | KDM4E (0.60) | KDM4EMEN1RECQLKMT2AALDH1A1 | |
| SCHEMBL10449001 | 0.89 | KMT2A (0.46) | KDM4EMEN1RECQLKMT2ALMNA | |
| SCHEMBL34470595 | 0.89 | KDM4E (0.60) | KDM4EMEN1RECQLKMT2AALDH1A1 | |
| SCHEMBL5167656 | 0.88 | POLM (0.60) | KDM4EMEN1RECQLKMT2AALDH1A1 | |
| SCHEMBL31094341 | 0.88 | POLM (0.60) | KDM4EMEN1RECQLKMT2AALDH1A1 | |
| SCHEMBL2058257 | 0.86 | KDM4E (0.53) | KDM4EMEN1KMT2AL3MBTL1TDP1 | |
| SCHEMBL28731739 | 0.85 | ALOX15 (0.45) | KDM4EMEN1RECQLKMT2ALMNA | |
| SCHEMBL28008237 | 0.84 | KDM4E (0.46) | KDM4EMEN1KMT2AL3MBTL1TDP1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-117683173-A | Polymer, resist composition, and pattern forming method | 信越化学工业株式会社 | 2024-03-12 | — | — | CN | disclosed |
| CN-116774520-A | Resist material and pattern forming method | 信越化学工业株式会社 | 2023-09-19 | — | — | CN | disclosed |
| CN-116774519-A | Resist material and pattern forming method | 信越化学工业株式会社 | 2023-09-19 | — | — | CN | disclosed |
| CN-111187235-B | Novel salt compound, chemically amplified resist composition, and pattern forming method | 信越化学工业株式会社 | 2023-06-06 | — | — | CN | disclosed |
| CN-116136645-A | Chemically amplified resist composition and pattern forming method | 信越化学工业株式会社 | 2023-05-19 | — | — | CN | disclosed |
| US-20120142771-A1 | BIPHENYLACETAMIDE DERIVATIVE | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2012-06-07 | — | — | US | disclosed |
| EP-2374790-A1 | BIPHENYLACETAMIDE DERIVATIVE | Dainippon Sumitomo Pharma Co., Ltd. (JP) | 2011-10-12 | — | — | EP | disclosed |
| US-20110224304-A1 | BIPHENYLACETAMIDE DERIVATIVE | DAINIPPON SUMITOMO PHARMA CO., LTD. (JP) | 2011-09-15 | — | — | US | disclosed |
| CN-1780822-A | Use of derivatives of 2, 4-dihydro- 1,2,4 triazole-3-thione as inhibitors of the enzyme myeloperoxidase (MPO) | ASTRAZENECA AB (SE) | 2006-05-31 | — | — | CN | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120142771-A1 | BIPHENYLACETAMIDE DERIVATIVE | HRH3, KCNH3, BRPF3 | KDM4E 829/4885MEN1 1467/4885RECQL 971/4885 |
| US-20110224304-A1 | BIPHENYLACETAMIDE DERIVATIVE | HRH3, KCNH3, BRPF3 | KDM4E 829/4885MEN1 1467/4885RECQL 971/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.